Title: Resolution No. (128) of 2023 Regarding the Cancellation of Listing of Yiaco Medical Company Shares from Boursa Kuwait Securities Exchange

Having Perused: 

- Law No. 7 of 2010 Regarding the Establishment of the Capital Markets Authority and Regulating Securities Activities, its Executive Bylaws, and their amendments; and 

- Based on CMA Board of Commissioners Resolution passed in its meeting No. (27) of 2023 held on 20/09/2023 Regarding the Cancellation of the Listing of Yiaco Medical Company Shares from Boursa Kuwait Securities Exchange.

The Following Was Resolved: 

Article (1)

The listing of Yiaco Medical Company’s Shares is hereby cancelled from Boursa Kuwait Securities Exchange, according to Items No. (3) and No. (8) of Article (2-4-1) of Module Twelve (Listing Rules) of the Executive Bylaws of Law No. 7 of 2010 Regarding the Establishment of the Capital Markets Authority and Regulating Securities Activities and their amendments, unless the Company addresses the reasons for the suspension and any other requirements that may arise within 4 and a half months from the CMA’s Resolution. The Company should provide the CMA with a weekly report on the progress made in resolving the suspension of its shares.

Article (2)

The concerned bodies shall execute this Resolution, each within its jurisdiction. This Resolution shall come into force from 24/09/2023, and it shall be published in the Official Gazette. 

Prof. Ahmad A. Al-Melhem 
Issued on: 24/09/2023.

Copy of the Official Document